129 related articles for article (PubMed ID: 6219961)
1. Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells.
Uchida A; Micksche M
Int J Cancer; 1983 Jan; 31(1):1-5. PubMed ID: 6219961
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
Uchida A; Micksche M; Hoshino T
Cancer Immunol Immunother; 1984; 18(1):5-12. PubMed ID: 6333269
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
Uchida A
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
[TBL] [Abstract][Full Text] [Related]
4. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
5. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
[TBL] [Abstract][Full Text] [Related]
6. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
Yanagawa E; Uchida A; Micksche M
Cancer Immunol Immunother; 1984; 17(1):1-6. PubMed ID: 6563940
[TBL] [Abstract][Full Text] [Related]
7. [Intratumoral administration of OK432 in rats with liver tumor].
Ishimaru M
Nihon Geka Gakkai Zasshi; 1988 Jun; 89(6):880-8. PubMed ID: 2972906
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
9. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
[TBL] [Abstract][Full Text] [Related]
10. Successful adoptive immunotherapy with OK432-inducible activated natural killer cells in tumor-bearing mice.
Yamaue H; Tanimura H; Iwahashi M; Tsunoda T; Tani M; Inoue M
Biotherapy; 1990; 2(1):51-61. PubMed ID: 2400628
[TBL] [Abstract][Full Text] [Related]
11. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
Kanda T; Yokoyama T; Suzuki T; Murata K
Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
[TBL] [Abstract][Full Text] [Related]
12. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
13. The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells.
Kurosawa S; Harada M; Shinomiya Y; Terao H; Nomoto K
Cancer Immunol Immunother; 1996 Sep; 43(1):31-8. PubMed ID: 8917633
[TBL] [Abstract][Full Text] [Related]
14. NK cells in carcinomatous and tuberculous pleurisy. Phenotypic and functional analyses of NK cells in peripheral blood and pleural effusions.
Okubo Y; Nakata M; Kuroiwa Y; Wada S; Kusama S
Chest; 1987 Sep; 92(3):500-4. PubMed ID: 3622027
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
16. Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: enhanced generation of soluble cytotoxic factors.
Uchida A; Klein E
Immunol Lett; 1985; 10(3-4):177-81. PubMed ID: 3899922
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Clinical response is not associated with evidence of enhancement of local cellular-mediated immunity.
Rossi GA; Felletti R; Balbi B; Sacco O; Cosulich E; Risso A; Melioli G; Ravazzoni C
Am Rev Respir Dis; 1987 Apr; 135(4):885-90. PubMed ID: 2436513
[TBL] [Abstract][Full Text] [Related]
18. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
Christmas SE; Meager A; Moore M
Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
[TBL] [Abstract][Full Text] [Related]
19. Intrapleural natural beta interferon in the treatment of malignant pleural effusions.
Rosso R; Rimoldi R; Salvati F; De Palma M; Cinquegrana A; Nicolò G; Ardizzoni A; Fusco U; Capaccio A; Centofanti R
Oncology; 1988; 45(3):253-6. PubMed ID: 2453008
[TBL] [Abstract][Full Text] [Related]
20. Combination of OK432 and human interferon-alpha for treating viral-induced diabetes mellitus in mice.
Kanda T; Kogure S; Nara M; Tsukui S; Utsugi T; Tomono S; Kawazu S; Nagai R; Kobayashi I
Eur J Pharmacol; 1998 Jan; 342(2-3):297-302. PubMed ID: 9548400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
